Effectdossier · gearchiveerd kwartaal
AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
18Gevolgde houders
0Δ houders
61.16MGehouden aandelen
$612.26MGerapporteerde waarde
+0Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.7% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | -4 | 106.56M | $1.84B | +7 | −10 |
| Q1 2026 | 107 | -1 | 100.53M | $1.25B | +9 | −11 |
| Q4 2025 | 109 | 0 | 106.30M | $1.34B | +1 | — |
| Q3 2025 | 18 | 0 | 61.16M | $612.26M | — | — |
| Q2 2025 | 15 | -1 | 52.63M | $425.79M | — | −1 |
| Q1 2025 | 13 | +3 | 21.14M | $177.14M | +3 | — |
| Q4 2024 | 10 | -1 | 20.64M | $163.48M | — | −1 |
| Q3 2024 | 10 | 0 | 16.87M | $140.36M | +2 | −2 |
| Q2 2024 | 10 | — | 16.56M | $105.19M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.73M | +1.9% | $57.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 5.73M | +1.9% | $57.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passief) | 4.03M | +7.3% | $40.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 4.03M | +7.3% | $40.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passief) | 3.97M | +1.5% | $39.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Millennium Management ✦ | 3.33M | -33.9% | $33.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 1.57M | +69.5% | $15.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 1.57M | +69.5% | $15.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Arrowstreet Capital ✦ | 1.30M | -23.5% | $12.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 56 | Fidelity (FMR) ✦ | 293.57K | +11.3% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 293.57K | +11.3% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 58 | T. Rowe Price ✦ | 137.69K | +5.4% | $1.38M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | Renaissance Technologies ✦ | 89.90K | -79.0% | $899,899 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 60 | Two Sigma Investments ✦ | 69.53K | +291.9% | $696,035 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 61 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 62 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 63 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 64 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 65 | Gotham Asset Management ✦ | 25.66K | -57.4% | $256,857 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 314 houders, 158.91M aandelen, $1.92B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Aug 13
Kiely John
Director · 50.00K aand · $882,000
Aug 12
Shah Nikita
Officer · 146.40K aand · $2.56M
Aug 12
Daly Jason B.
Officer · 210.00K aand · $3.65M
Aug 11
Daly Jason B.
Officer · 6.61K aand · $117,050
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Aug 12
SC 13D/A — Patel Tushar Bhikhubhai
17.6% van klasse · Originele SEC-indiening bekijken ↗
Aug 12
SC 13D/A — Patel Chirag K.
8.4% van klasse · Originele SEC-indiening bekijken ↗
Aug 12
SC 13D/A — Patel Chintu
9.4% van klasse · Originele SEC-indiening bekijken ↗
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API